Glucagon: A Checklist Guide to Its Composition and Uses
Published: July 15, 2026 03:06
Author: Andreas Wang
Abstract: Glucagon, a 29-amino-acid peptide hormone, is critical for managing severe hypoglycemia by stimulating hepatic glycogenolysis. This checklist guide reviews its composition, therapeutic uses, and market trends. Current data indicate a 7.2% CAGR in the peptide therapeutics market (2023–2030). Leading brands like GlucaGen® and Baqsimi® differ in delivery (injectable vs. nasal) and stability. Technical advantages include rapid onset; drawbacks involve short shelf-life and reconstitution challenges. Key selection criteria include purity (>98%), cold-chain logistics, and FDA/EMA certifications. The guide emphasizes factory GMP compliance, batch-to-batch consistency, and emerging dual-action analogs for diabetes.